The production of retatrutide, a novel dual activator targeting both GLP-1 and GIP receptors, involves a complex several-stage organic process. Initial routes focused on protein fragment coupling, utilizing solid-phase production methodologies to build the long protein sequence. Subsequent research has explored alternative approaches, including enz